Occudo Quantitative Strategies’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.41M Sell
84,546
-128,717
-60% -$2.77M 0.13% 234
2026
Q1
$3.94M Buy
+213,263
New +$3M 0.21% 140
2024
Q4
Sell
-17,600
Closed -$373K 871
2024
Q3
$373K Buy
17,600
+6,483
+58% +$117K 0.07% 368
2024
Q2
$176K Buy
+11,117
New +$204K 0.03% 617
2023
Q4
Sell
-60,095
Closed -$335K 1085
2023
Q3
$335K Buy
+60,095
New +$421K 0.04% 630
2022
Q4
Sell
-128,921
Closed -$643K 1258
2022
Q3
$643K Sell
128,921
-190,611
-60% -$1.11M 0.05% 580
2022
Q2
$1.36M Buy
319,532
+239,426
+299% +$1.52M 0.11% 284
2022
Q1
$799K Buy
80,106
+3,282
+4% +$24.4K 0.07% 459
2021
Q4
$603K Buy
+76,824
New +$965K 0.05% 555

Other funds holding OSCR

Occudo Quantitative Strategies's OSCR Position: Q2 2026 in Review

Occudo Quantitative Strategies reduced its Oscar Health (OSCR) stake by 60% in Q2 2026, selling an estimated $2.77M and leaving 84,546 shares worth $2.41M. The position accounts for 0.13% of the portfolio, ranked #234.

Occudo Quantitative Strategies first reported a position in OSCR in Q4 2021 and has held it in 9 quarters since. The position peaked at $3.94M in Q1 2026. 403 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • Occudo Quantitative Strategies held 84,546 shares of Oscar Health worth $2.41M as of Q2 2026.
  • Occudo Quantitative Strategies sold 128,717 Oscar Health shares in Q2 2026, an estimated $2.77M.
  • Oscar Health made up 0.13% of Occudo Quantitative Strategies's portfolio in Q2 2026, its #234 holding.
  • Occudo Quantitative Strategies first reported a position in Oscar Health in Q4 2021 and has held it in 9 quarters since.
  • Occudo Quantitative Strategies's Oscar Health position peaked at $3.94M in Q1 2026.
  • 403 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.